Page last updated: 2024-08-25

methotrexate and Osteoporosis, Postmenopausal

methotrexate has been researched along with Osteoporosis, Postmenopausal in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamada, T; Hara, T; Jingushi, S; Kamo, Y; Maekawa, M; Miyanishi, K; Moro-oka, TA; Torisu, T; Tsurusaki, S1
Lewiecki, EM1
Bazakas, A; Ladizinski, B; Olsen, EA; Selim, MA1
Espirito, JL; Games, DM; McCune, JS1
Briot, K1
Náfrádi, L; Toldy, E; Varga, L1
Gündüz, OH; Ozoran, K; Uçan, H; Yilmaz, L; Yücel, M1
Beresford, JN; Bhalla, AK; Compston, JE; Kounali, D; Minaur, NJ; Vedi, S1

Reviews

2 review(s) available for methotrexate and Osteoporosis, Postmenopausal

ArticleYear
Denosumab for joints and bones.
    Current rheumatology reports, 2009, Volume: 11, Issue:3

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Denosumab; Drug Therapy, Combination; Female; Humans; Joints; Methotrexate; Middle Aged; Osteoclasts; Osteoporosis, Postmenopausal; RANK Ligand

2009
[Non-corticosteroid drug-induced metabolic bone disease].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:10 Pt 2

    Topics: Aged; Animals; Anticoagulants; Anticonvulsants; Antipsychotic Agents; Aromatase Inhibitors; Bone Density; Child; Cyclosporins; Densitometry; Disease Progression; Diuretics; Female; Follow-Up Studies; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Iatrogenic Disease; Immunosuppressive Agents; Lithium Compounds; Male; Menopause; Methotrexate; Middle Aged; Osteomalacia; Osteoporosis; Osteoporosis, Postmenopausal; Placebos; Prospective Studies; Protease Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tacrolimus; Thyroid Hormones; Time Factors

2006

Trials

3 trial(s) available for methotrexate and Osteoporosis, Postmenopausal

ArticleYear
[Measure of bone loss in rheumatoid arthritis].
    Orvosi hetilap, 1999, Feb-07, Volume: 140, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Arthritis, Rheumatoid; Bone Diseases, Metabolic; Densitometry; Female; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal

1999
Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids.
    Rheumatology international, 2001, Volume: 20, Issue:2

    Topics: Absorptiometry, Photon; Aged; Alendronate; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Calcium; Clinical Chemistry Tests; Drug Therapy, Combination; Female; Hematologic Tests; Humans; Methotrexate; Middle Aged; Osteoporosis, Postmenopausal; Prednisolone; Treatment Outcome

2001
Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density.
    Rheumatology (Oxford, England), 2002, Volume: 41, Issue:7

    Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Dose-Response Relationship, Drug; Female; Humans; Male; Methotrexate; Middle Aged; Osteoporosis, Postmenopausal; Outpatient Clinics, Hospital; Prospective Studies; Sulfasalazine

2002

Other Studies

3 other study(ies) available for methotrexate and Osteoporosis, Postmenopausal

ArticleYear
Co-occurrence of subchondral insufficiency fracture of the femoral head and contralateral femoral neck fracture in a rheumatic patient receiving steroid treatment.
    Modern rheumatology, 2008, Volume: 18, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diagnosis, Differential; Drug Therapy, Combination; Female; Femoral Neck Fractures; Femur Head; Fractures, Stress; Hip Fractures; Hip Joint; Humans; Magnetic Resonance Imaging; Methotrexate; Osteonecrosis; Osteoporosis, Postmenopausal; Prednisolone

2008
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
    Journal of the American Academy of Dermatology, 2013, Volume: 68, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Anti-Bacterial Agents; Azasteroids; Cicatrix; Dutasteride; Enzyme Inhibitors; Eyebrows; Female; Fibrosis; Forehead; Hospitals, University; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lichen Planus; Methotrexate; Middle Aged; Minocycline; Osteoporosis, Postmenopausal; Retrospective Studies; Scalp; Tacrolimus; Treatment Outcome

2013
Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2005, Volume: 11, Issue:2

    Topics: Absorptiometry, Photon; Administration, Oral; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Breast Neoplasms; Calcium; Contraceptives, Oral; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Utilization Review; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Follow-Up Studies; Goserelin; Humans; Medical Records; Menstruation Disturbances; Methotrexate; Osteoporosis, Postmenopausal; Premenopause; Primary Ovarian Insufficiency; Process Assessment, Health Care; Retrospective Studies; Survivors; Tamoxifen; Time Factors

2005